Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Breast cancer PAINT: a first-in-human, dose-escalation study to determine the safety of Plasma Adjuvant INtra-operative Treatment in breast cancer patients

Original Submission
4 Sep 2024 Submitted Original manuscript
11 Nov 2024 Reviewed Reviewer Report
27 Feb 2025 Reviewed Reviewer Report
22 Mar 2025 Author responded Author comments - Philip Wong
Resubmission - Version 2
22 Mar 2025 Submitted Manuscript version 2
2 Apr 2025 Reviewed Reviewer Report
9 Apr 2025 Reviewed Reviewer Report
10 Apr 2025 Author responded Author comments - Philip Wong
Resubmission - Version 3
10 Apr 2025 Submitted Manuscript version 3
11 Apr 2025 Author responded Author comments - Philip Wong
Resubmission - Version 4
11 Apr 2025 Submitted Manuscript version 4
Publishing
14 Apr 2025 Editorially accepted
22 Apr 2025 Article published 10.1186/s12885-025-14153-5

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us